- Home
- AMIX
as 11-21-2024 4:00pm EST
Stocks
Autonomix Medical Inc is a development-stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | THE WOODLANDS |
| Market Cap: | 8.9M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 1.5M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -15.26 | EPS Growth: | N/A |
| 52 Week Low/High: | $7.51 - $152.00 | Next Earning Date: | 11-11-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest AUTONOMIX MEDICAL INC News
AMIX Breaking Stock News: Dive into AMIX Ticker-Specific Updates for Smart Investing
GlobeNewswire
11 days ago
Autonomix Medical, Inc. Reports Second Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update
GlobeNewswire
22 days ago
Autonomix Medical, Inc. Reports New Positive Topline Results from First 15 Patients’ 7-Day Data Highlighting Significant Impact on Treatment of Pancreatic Cancer Pain with Maintained Pain Reduction
GlobeNewswire
23 days ago
Autonomix Medical, Inc.’s Dr. Robert Schwartz Discusses What Positive 4-6 Week Follow-Up Data Means from Lead-In Patients in Ongoing Human Clinical Trial
GlobeNewswire
25 days ago
Positive Preliminary Results Demonstrate Autonomix’s Proprietary RF Ablation Technology’s Ability to Reduce Opioid Use in Ongoing Human Clinical Trial
GlobeNewswire
a month ago
Autonomix Medical, Inc. to Participate in a Virtual Investor “What This Means” Segment on Wednesday, October 30th
GlobeNewswire
a month ago
Autonomix Announces Reverse Stock Split
GlobeNewswire
a month ago
Autonomix Medical, Inc. to Participate in the 2024 Healthcare Virtual Summit, Presented by Maxim Group LLC
ACCESSWIRE
2 months ago
This Company Is Taking An Innovative, Non-Opioid Approach To Pain Management For Pancreatic Cancer
Compare AMIX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "AMIX AUTONOMIX MEDICAL INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.